Rare diseases
Investigational molecules
Locations
Back to Spain371 clinical trials in Palma, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on the Effects of ELGN-2112 (Human Insulin) for Treating Intestinal Malabsorption in Preterm Infants
SpainEfficacy and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Face and Neck Atopic Dermatitis
SpainA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
SpainStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
SpainA Phase 2 Study Evaluating the Safety and Efficacy of Oral NS-863 in Adults with Pulmonary Hypertension Associated with Interstitial Lung Disease
SpainSpainStudy of Once‑Weekly Eloralintide (LY3841136 Sodium) in Adults with Obesity or Overweight, Type 2 Diabetes, and High Cardiovascular Risk
SpainStudy of elranatamab, mezigdomide and dexamethasone in patients with relapsed/refractory multiple myeloma
SpainSpainPhase 2 Randomized Trial of Oral NS-863 in Patients with Pulmonary Arterial Hypertension
SpainA Phase 3 Study of Once‑Daily Treprostinil Palmitil Inhalation Powder for Adults with Pulmonary Arterial Hypertension
SpainRandomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis
SpainThe busiest research cities in the country
What the registry says about research in the country
The cancer research activity in Palma De Mallorca focuses on improving treatment options for multiple myeloma, relapsed refractory multiple myeloma, acute myeloid leukemia, myelodysplastic syndrome, and advanced non-small cell lung cancer. These studies are designed to assess whether newer therapies can improve disease control and patient outcomes.
Across these trials, researchers are comparing innovative approaches with existing care to better understand how to extend survival and deepen responses.
Clinical trial work in cardiovascular diseases is centered on primary prevention of atherosclerotic cardiovascular disease. The main goal is to see whether new preventive strategies can lower the risk of serious heart and vascular events in people at elevated risk.
These studies aim to strengthen early prevention and support better long-term cardiovascular health.
This research area includes studies in hematologic cancers such as multiple myeloma, relapsed refractory multiple myeloma, acute myeloid leukemia, and myelodysplastic syndrome. The focus is on testing therapies that may improve control of blood-related malignancies and deepen treatment responses.
Investigators are working to refine treatment strategies for patients with difficult-to-treat hematologic conditions.
Trials in nervous system diseases are exploring better ways to prevent and ease chronic postsurgical pain after inguinal hernia repair. The aim is to reduce the chance that short-term surgical pain becomes a lasting problem.
These studies focus on making recovery more comfortable and helping patients return to normal activity more smoothly.
Research in stomatognathic diseases is examining ways to prevent clinically relevant oral bleeding after tooth extraction in patients using direct oral anticoagulants or vitamin K antagonists. The purpose is to improve safety in everyday dental care for people on blood-thinning treatment.
These studies aim to support safer dental procedures without compromising cardiovascular protection.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
